Navigation Links
Interrupting death messages to treat bone disease
Date:9/6/2010

A surface molecule on bacteria that instructs bone cells to die could be the target for new treatments for bone disease, says a scientist speaking at the Society for General Microbiology's autumn meeting today.

Blocking the death signal from bacteria could be a way of treating painful bone infections that are resistant to antibiotics, such as those caused by Meticillin-resistant Staphylococcus aureus (MRSA).

Bone disease, or osteomyelitis, affects 1 in 5,000 people around the world. It can occur at any stage in life and attack any bone in the body, where it leads to progressive bone destruction.

Osteomyelitis is usually caused by the bacterium Staphylococcus aureus that lives commonly on human skin and in the nose. It can reach the bones through open wounds or during surgery and most often causes infections in people with compromised immune systems.

Research led by Dr. Steve Kerrigan from the Royal College of Surgeons in Ireland in collaboration with Trinity College Dublin has revealed that the ability of S. aureus to latch onto bone cells depends on a specific protein called Spa, which is presented on the bacterium's surface. Once attached to the bone cell, the bacteria transmit signals prompting the bone cell to commit suicide. This causes a gradual loss of bone cells leading to progressive bone destruction and weakening of the skeletal system.

Ms Tania Claro who is presenting the group's work explained how the group's findings could lead to new therapies for osteomyelitis. "Bacteria that do not have the Spa protein on their surface are unable to bind to bone cells, which prevents them from sending suicide messages," she said. "Blocking bacterial attachment to cells via Spa could therefore be a way of treating osteomyelitis, or even preventing it in the first place."

Therapies that could effectively prevent and/or treat osteomyelitis could greatly improve the quality of life of sufferers. "This disease is very painful for patients and frustrating for both them and their doctors." explained Ms Claro. Current treatment involves prolonged aggressive antibiotic therapy, however this approach is often less than successful and surgical debridement is required.

New treatments for the disease that do not rely on existing antibiotics would be advantageous. "The danger of invasive bacterial disease is compounded by the rapid emergence of multi-drug resistant bacteria worldwide," explained Ms Claro. "The findings of this study will help develop better diagnostic tools and treatments for osteomyelitis that will not over-rely on antibiotics."


'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert

Related biology news :

1. Breast cancer cells recycle to escape death by hormonal therapy
2. Genes that control cell death fingered in age-related hearing loss
3. Caltech geobiologists discover unique magnetic death star fossil
4. Forced evolution: Can we mutate viruses to death?
5. Drops in blood oxygen levels may be key to sudden death in some epilepsy patients
6. New technology aims to reduce maternal and neonatal deaths
7. Fewer deaths with preventive antibiotic use
8. Burnham researchers discover on switch for cell death signaling mechanism
9. Study helps explain connection between sleep apnea, stroke and death
10. Stroke Belt deaths tied to non-traditional risk factors
11. Jefferson scientists discover a key protein regulator of inflammation and cell death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell , ... technology, and STMicroelectronics (NYSE: STM), a global ... electronics applications, announced today the launch of a ... biometric wearables that includes ST,s compact SensorTile ... Benchmark™ biometric sensor system. Together, SensorTile and ...
(Date:12/15/2016)... Germany , December 15, 2016 ... today announced an agreement with NuData Security, an award-winning ... The partnership will enable clients to focus on good customer ... data protection regulation. ... In order to provide a one-stop fraud prevention ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017 AquaBounty Technologies, Inc. (AIM: ABTU; ... in aquaculture and a majority-owned subsidiary of Intrexon Corporation ... completed the listing of its common shares on the ... Intrexon. "AquaBounty,s listing on NASDAQ represents an ... exposure to the U.S. markets as we advance plans ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... of drug and device development, and Prism Clinical Research , a leader ... announced Verified Clinical Trials (VCT) has been selected by both companies ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
Breaking Biology Technology: